Clinical value of atezolizumab plus bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis Meeting Abstract
| Authors: | Vogel, A.; Rimassa, L.; Sun, H. C.; Abou-Alfa, G. K.; El-Khoueiry, A. B.; Pinato, D. J.; Daigl, M.; Alvarez, J. S.; Orfanos, P.; Leibfried, M.; Zumofen, M. H. B.; Gaillard, V.; Merle, P. |
| Abstract Title: | Clinical value of atezolizumab plus bevacizumab for first-line unresectable hepatocellular carcinoma (HCC): A network meta-analysis |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302198 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.4585 |
| Notes: | Meeting Abstract: 4585 -- Source: Wos |
